This report aims to provide a comprehensive presentation of the global market for Low-density Lipoprotein Apheresis Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Low-density Lipoprotein Apheresis Therapy. This report contains market size and forecasts of Low-density Lipoprotein Apheresis Therapy in global, including the following market information:
Global Low-density Lipoprotein Apheresis Therapy Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Low-density Lipoprotein Apheresis Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Double Filtration LDL Apheresis Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Low-density Lipoprotein Apheresis Therapy include Kaneka Pharma, B.Braun, Fresenius Medical Care, Asahi Kasei Medical, Medicap, Kawasumi Laboratories, Terumo Corporation and Haemonetics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Low-density Lipoprotein Apheresis Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Low-density Lipoprotein Apheresis Therapy Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, by Type, 2022 (%)
Double Filtration LDL Apheresis Therapy
Cascade Filtration LDL Apheresis Therapy
Global Low-density Lipoprotein Apheresis Therapy Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, by Application, 2022 (%)
Atherosclerosis Patient
Obesity Patient
Dyslipidemia Patient
Coronary Heart Disease Patient
Carotid Artery Disease Patient
Global Low-density Lipoprotein Apheresis Therapy Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Low-density Lipoprotein Apheresis Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Low-density Lipoprotein Apheresis Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Low-density Lipoprotein Apheresis Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kaneka Pharma
B.Braun
Fresenius Medical Care
Asahi Kasei Medical
Medicap
Kawasumi Laboratories
Terumo Corporation
Haemonetics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Low-density Lipoprotein Apheresis Therapy, market overview.
Chapter 2: Global Low-density Lipoprotein Apheresis Therapy market size in revenue.
Chapter 3: Detailed analysis of Low-density Lipoprotein Apheresis Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Low-density Lipoprotein Apheresis Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Low-density Lipoprotein Apheresis Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Low-density Lipoprotein Apheresis Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Low-density Lipoprotein Apheresis Therapy Overall Market Size
2.1 Global Low-density Lipoprotein Apheresis Therapy Market Size: 2022 VS 2029
2.2 Global Low-density Lipoprotein Apheresis Therapy Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Low-density Lipoprotein Apheresis Therapy Players in Global Market
3.2 Top Global Low-density Lipoprotein Apheresis Therapy Companies Ranked by Revenue
3.3 Global Low-density Lipoprotein Apheresis Therapy Revenue by Companies
3.4 Top 3 and Top 5 Low-density Lipoprotein Apheresis Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Low-density Lipoprotein Apheresis Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Low-density Lipoprotein Apheresis Therapy Players in Global Market
3.6.1 List of Global Tier 1 Low-density Lipoprotein Apheresis Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Low-density Lipoprotein Apheresis Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Low-density Lipoprotein Apheresis Therapy Market Size Markets, 2022 & 2029
4.1.2 Double Filtration LDL Apheresis Therapy
4.1.3 Cascade Filtration LDL Apheresis Therapy
4.2 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue & Forecasts
4.2.1 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2023
4.2.2 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2024-2029
4.2.3 By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Low-density Lipoprotein Apheresis Therapy Market Size, 2022 & 2029
5.1.2 Atherosclerosis Patient
5.1.3 Obesity Patient
5.1.4 Dyslipidemia Patient
5.1.5 Coronary Heart Disease Patient
5.1.6 Carotid Artery Disease Patient
5.2 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue & Forecasts
5.2.1 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2023
5.2.2 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2024-2029
5.2.3 By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Low-density Lipoprotein Apheresis Therapy Market Size, 2022 & 2029
6.2 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue & Forecasts
6.2.1 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2023
6.2.2 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue, 2024-2029
6.2.3 By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2029
6.3.2 US Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.3.3 Canada Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.3.4 Mexico Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2029
6.4.2 Germany Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4.3 France Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4.4 U.K. Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4.5 Italy Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4.6 Russia Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4.7 Nordic Countries Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.4.8 Benelux Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2029
6.5.2 China Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.5.3 Japan Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.5.4 South Korea Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.5.5 Southeast Asia Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.5.6 India Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2029
6.6.2 Brazil Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.6.3 Argentina Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2029
6.7.2 Turkey Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.7.3 Israel Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.7.4 Saudi Arabia Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
6.7.5 UAE Low-density Lipoprotein Apheresis Therapy Market Size, 2018-2029
7 Low-density Lipoprotein Apheresis Therapy Companies Profiles
7.1 Kaneka Pharma
7.1.1 Kaneka Pharma Company Summary
7.1.2 Kaneka Pharma Business Overview
7.1.3 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.1.4 Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.1.5 Kaneka Pharma Key News & Latest Developments
7.2 B.Braun
7.2.1 B.Braun Company Summary
7.2.2 B.Braun Business Overview
7.2.3 B.Braun Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.2.4 B.Braun Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.2.5 B.Braun Key News & Latest Developments
7.3 Fresenius Medical Care
7.3.1 Fresenius Medical Care Company Summary
7.3.2 Fresenius Medical Care Business Overview
7.3.3 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.3.4 Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.3.5 Fresenius Medical Care Key News & Latest Developments
7.4 Asahi Kasei Medical
7.4.1 Asahi Kasei Medical Company Summary
7.4.2 Asahi Kasei Medical Business Overview
7.4.3 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.4.4 Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.4.5 Asahi Kasei Medical Key News & Latest Developments
7.5 Medicap
7.5.1 Medicap Company Summary
7.5.2 Medicap Business Overview
7.5.3 Medicap Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.5.4 Medicap Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.5.5 Medicap Key News & Latest Developments
7.6 Kawasumi Laboratories
7.6.1 Kawasumi Laboratories Company Summary
7.6.2 Kawasumi Laboratories Business Overview
7.6.3 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.6.4 Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.6.5 Kawasumi Laboratories Key News & Latest Developments
7.7 Terumo Corporation
7.7.1 Terumo Corporation Company Summary
7.7.2 Terumo Corporation Business Overview
7.7.3 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.7.4 Terumo Corporation Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.7.5 Terumo Corporation Key News & Latest Developments
7.8 Haemonetics
7.8.1 Haemonetics Company Summary
7.8.2 Haemonetics Business Overview
7.8.3 Haemonetics Low-density Lipoprotein Apheresis Therapy Major Product Offerings
7.8.4 Haemonetics Low-density Lipoprotein Apheresis Therapy Revenue in Global Market (2018-2023)
7.8.5 Haemonetics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Low-density Lipoprotein Apheresis Therapy Market Opportunities & Trends in Global Market
Table 2. Low-density Lipoprotein Apheresis Therapy Market Drivers in Global Market
Table 3. Low-density Lipoprotein Apheresis Therapy Market Restraints in Global Market
Table 4. Key Players of Low-density Lipoprotein Apheresis Therapy in Global Market
Table 5. Top Low-density Lipoprotein Apheresis Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Low-density Lipoprotein Apheresis Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Low-density Lipoprotein Apheresis Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Low-density Lipoprotein Apheresis Therapy Product Type
Table 9. List of Global Tier 1 Low-density Lipoprotein Apheresis Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Low-density Lipoprotein Apheresis Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Low-density Lipoprotein Apheresis Therapy Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2024-2029
Table 30. Kaneka Pharma Company Summary
Table 31. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 32. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Kaneka Pharma Key News & Latest Developments
Table 34. B.Braun Company Summary
Table 35. B.Braun Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 36. B.Braun Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. B.Braun Key News & Latest Developments
Table 38. Fresenius Medical Care Company Summary
Table 39. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 40. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Fresenius Medical Care Key News & Latest Developments
Table 42. Asahi Kasei Medical Company Summary
Table 43. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 44. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Asahi Kasei Medical Key News & Latest Developments
Table 46. Medicap Company Summary
Table 47. Medicap Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 48. Medicap Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Medicap Key News & Latest Developments
Table 50. Kawasumi Laboratories Company Summary
Table 51. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 52. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Kawasumi Laboratories Key News & Latest Developments
Table 54. Terumo Corporation Company Summary
Table 55. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 56. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Terumo Corporation Key News & Latest Developments
Table 58. Haemonetics Company Summary
Table 59. Haemonetics Low-density Lipoprotein Apheresis Therapy Product Offerings
Table 60. Haemonetics Low-density Lipoprotein Apheresis Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Haemonetics Key News & Latest Developments
List of Figures
Figure 1. Low-density Lipoprotein Apheresis Therapy Segment by Type in 2022
Figure 2. Low-density Lipoprotein Apheresis Therapy Segment by Application in 2022
Figure 3. Global Low-density Lipoprotein Apheresis Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Low-density Lipoprotein Apheresis Therapy Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Low-density Lipoprotein Apheresis Therapy Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Low-density Lipoprotein Apheresis Therapy Revenue in 2022
Figure 8. By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 9. By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 10. By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 12. By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 14. By Region - Global Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 15. By Country - North America Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 16. US Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 20. Germany Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 21. France Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 28. China Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 32. India Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 34. Brazil Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Low-density Lipoprotein Apheresis Therapy Revenue Market Share, 2018-2029
Figure 37. Turkey Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Low-density Lipoprotein Apheresis Therapy Revenue, (US$, Mn), 2018-2029
Figure 41. Kaneka Pharma Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. B.Braun Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Fresenius Medical Care Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Asahi Kasei Medical Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Medicap Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Kawasumi Laboratories Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Terumo Corporation Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Haemonetics Low-density Lipoprotein Apheresis Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
